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Asians compared to Europeans in Norway and New Zealand?
KS Kjersti Stormark Rabanal1, HE Meyer1, GS Tell2, J Igland2, R Pylypchuk3,
S Mehta3, B Kumar4, AK Jenum5, RM Selmer1, RT Jackson3
1Norwegian Institute of Public Health, Oslo, Norway, 2University of Bergen, Bergen, Norway, 3The
University of Auckland, Auckland, New Zealand, 4Oslo University Hospital, Oslo, Norway,
5University of Oslo, Oslo, Norway
Funding Acknowledgements: This study was funded by the Norwegian Extra-
Foundation for Health and Rehabilitation (grant number 2012-2-0129)
Topic: Social inequalities in cardiovascular health
Introduction: Immigrants from South Asia have increased risk of cardiovascular disease
(CVD) compared to Europeans. The reasons for this excess risk are unclear, and the role
of traditional risk factors is unsettled. The prospective relations between risk factors and
subsequent CVD in South Asian populations have been scarcely studied.
Purpose The purpose of this study was to examine ethnic differences between South Asians
and Europeans living in Norway and New Zealand in the risk of having a ﬁrst CVD event,
and to examine whether traditional risk factors (blood pressure, lipids, diabetes and smoking)
could explain any such difference. Our purpose was also to describe the prospective relation
between cardiovascular risk factors and subsequent ﬁrst CVD events in South Asians and
Europeans.
Methods: We used data from two different cohorts; a Norwegian (Cohort of Norway, n=16
606) and a New Zealand cohort (PREDICT-CVD, n=129 449) with information about
ethnicity, cardiovascular risk factors and subsequent CVD through linkages with hospital
registry data and causes of death registers in both countries. The two cohorts were analyzed
separately. We used Cox proportional hazards regression to calculate hazard ratios (HRs) for
CVD in South Asians versus Europeans and to study the prospective relation between risk
factors and subsequent ﬁrst CVD.
Results: South Asians in both Norway and New Zealand had higher total cholesterol /high
density lipoprotein ratio and higher diabetes prevalence at baseline than Europeans, but lower
levels of systolic blood pressure and smoked less (especially women). The cardiovascular risk
factors were in general positively associated with CVD in both ethnic groups, across gender
and country. South Asians of both genders in Norway and New Zealand had increased risk of
CVD compared to the European majority populations being 87-92% higher in the Norwegian
cohort and 42-75% higher in the New Zealand cohort. After having adjusted for blood
pressure, lipids, diabetes and smoking, South Asians in both countries remained at having
signiﬁcantly increased risk of CVD with hazard ratios (HRs) for South Asians vs Europeans
in the Norwegian cohort being 1.57; 95% CI 1.19-2.07 in men and 1.76; 95% CI 1.09-2.82 in
women and HRs for South Asians vs Europeans in the New Zealand cohort being 1.64; 95%
CI 1.43-1.88 in men and 1.39; 95% CI 1.11-1.73 in women.
Conclusion: Differences in distribution of cardiovascular risk factors seemed to explain some,
but not all, of the excess risk of CVD in South Asians compared to Europeans in Norway and
New Zealand.
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Social inequalities in the burden of stroke in Germany: cross-sectional analysis of a
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Topic: Social inequalities in cardiovascular health
Background: Social inequalities in stroke risk and outcomes have been reported for many
countries. Knowledge of existing inequalities in speciﬁc countries and populations is impor-
tant for effective stroke prevention and management.
Purpose: To examine (1) the association between socioeconomic status (SES) and the preva-
lence of stroke and (2) health inequalities among stroke survivors in the general population in
Germany.
Methods: We analysed pooled data from waves 2009, 2010 and 2012 of the nationwide popu-
lation-based study German Health Update (GEDA) with a total of 62,446 participants aged 
18 years. Data on self-reported physician-diagnosed stroke, sociodemographic characteristics,
chronic diseases, health status, and healthcare utilization were collected by standardized
computer-assisted telephone interviews. Socioeconomic status (SES) was classiﬁed as low,
medium and high using an index based on information on education, occupational status
and net equivalent income. The association between SES and stroke prevalence was examined
in multivariable logistic regression analysis. Differences between SES groups in health status
and healthcare use after stroke were examined by regression models that included interaction
terms for SES*stroke and that were adjusted for sociodemographics and comorbidities.
Results: The lifetime prevalence of stroke among adults in Germany was 2.5% overall, 2.4%
in women and 2.6% in men. Prevalence ranged from 1.6% in people with high SES to 2.4% in
those with medium and 4.1% in those with high SES (p(trend)<0.001). In age- and sex-
stratiﬁed analyses, similar social gradients existed in all subgroups. Adjusting for age, sex,
region, community size and study wave, a lower SES was associated with signiﬁcantly higher
odds of stroke (odds ratio (OR) for medium vs. high SES, 1.4 (95% CI, 1.2-1.6); OR for low
vs. high SES, 1.9 (95% CI, 1.5-2.4)). Adjusting for all sociodemographics and comorbidities,
participants with a lifetime history of stroke more often reported bad or very bad self-rated
health (OR, 1.9; 95% CI, 1.6-2.3), severe global activity limitations in the last 6 months (OR,
1.8; 95% CI, 1.5-2.2), frequent mental distress in the last 4 weeks (OR, 1.4; 95% CI, 1.2-1.8),
and at least one hospital admission in the last 12 months (OR 1.8; 95% CI, 1.5-2.1), compared
to participants without stroke. No difference between SES groups were found for these health
outcomes (all p for interaction SES*stroke >0.1).
Conclusions: Lower SES is associated with higher stroke prevalence among adults in
Germany. This social gradient is found in men and women and across all age groups and
persists after adjustment for sociodemographic confounders. Lifetime history of stroke is
associated with poorer health status and use of hospital admission independently of comor-
bidities in adjusted analyses, but outcomes did not differ between SES groups.
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Topic: Psycho-social risk factors
Background: Vital exhaustion (VE)  a measure of fatigue, hopelessness and depression  has
been shown as an independent risk factor for ischemic heart disease (IHD) in the general
population. In addition, resting heart rate (RHR) has been observed as an independent pre-
dictor of cardiovascular mortality. It is possible that both factors act through the same under-
lying mechanisms, and thus they may potentiate each other in affecting risk of death from
IHD. However, this remains so far unknown.
Purpose: To investigate the interplay between VE, RHR and IHD mortality in the general
population.
Methods: Participants from the third wave of the Copenhagen City Heart Study (1991-1994)
without history of IHD or atrial ﬁbrillation were followed for fatal IHD (ICD-10: I20-I25)
until the end of 2012. The ﬁnal sample included 8810 participants (5009 females and 3801
males) aged 21  94 years (mean 57.1, s.d. 15.2). Data were collected at baseline through self-
administered questionnaires and bio-clinical assessments. A questionnaire with 17 dichoto-
mous items was used to assess level of VE. RHR was read from a 12-lead ECG at rest.
Statistical analyses were performed using Analysis of Covariance, and Cox proportional
regression modeling adjusted for conventional cardiovascular risk factors, educational level
and income.
Results: During the median follow-up time of 19 years, 583 persons died from IHD. At
baseline, the association between VE and RHR depended on sex (P for interaction term
<0.05). In men, gradually higher RHR was observed with higher levels of VE, independent
of age and socio-economic status. In women, no signiﬁcant independent relation was shown.
Both VE and RHR signiﬁcantly and independently increased the risk for IHD mortality, also
after stepwise adjusting for age, sex, cardiovascular risk factors and indicators of low socio-
economic status (VE: fully adjusted HR per unit increase 1.04; 95%CI 1.03-1.06 and RHR:
fully adjusted HR per 10 bpm increase 1.04; 95% CI 1.00-1.08). We further examined the
combined exposure to low vs. high levels of VE (high level deﬁned as minimum 5 on the 0-17
scale; prevalence 24.7%) and RHR (high level deﬁned as minimum of 80 bpm; prevalence
27.3%) (Figure 1). Neither high VE nor high RHR alone were signiﬁcantly associated with
fatal IHD, but the combination of both high VE and high RHR signiﬁcantly increased the risk
for IHD mortality compared with the combination of low VE and low RHR (fully adjusted
HR 1.87; 95% CI 1.40-2.50).
Conclusions: The combination of high RHR with VE synergistically increased the risk for
death from IHD in a general population free from baseline cardiovascular disease. Both
factors are easy to screen in primary care setting, hence these ﬁndings might have relevant




Association between dietary fat intake and coronary heart disease in middle-aged
and senior adults. The Hordaland Health Studies (HUSK).
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Topic: Epidemiology
Background: The association between type of dietary fat and the risk of coronary heart disease
(CHD) remains debatable. Several risk factors for coronary heart disease (CHD) have been
observed to be less pronounced among senior adults than among middle-aged adults given the
importance of advancing age as a key risk factor for CHD, but age-differences in the impor-
tance of dietary intakes have not been evaluated.
Purpose: To investigate the association between different dietary fat intakes and incident CHD
in middle-aged and senior adults.
Methods:We included in the analyses 5517 men and women aged 4749 (N=2995) and 7174
(N=2522) years participating in the Hordaland Health study (HUSK) without history of
CHD who completed a 169-item food frequency questionnaire in 199799 (baseline). They
were followed until 31 December 2009 for a coronary event (either hospitalization or death
due to CHD). The associations between type of dietary fat and CHD were explored using Cox
regression analysis. Results are provided as hazard ratio (HR) and 95% conﬁdence intervals
(CI). We modeled isocaloric substitution analysis to evaluate the effect of substituting part of
the total energy intake from one dietary source with a different dietary source. Analyses were
adjusted for age, gender, diabetes, hypertension, physical activity, smoking, body mass index
and cholesterol intake.
Results: During a median follow-up of 10.9 years, we documented 112 incident cases in the
middle-aged population and 492 incident cases among senior adults. In the middle-aged
adults, a higher intake of monounsaturated fatty acids (MUFA) was signiﬁcantly associated
with reduced risk of CHD (HR for the highest versus the lowest quintile 0.46, 95% CI:
0.240.90). P trend for intake of MUFA in the middle-aged population was 0.01. Saturated
fat (SFA) and polyunsaturated fat (PUFA) intake was not associated with the risk of CHD in
either senior adults or middle-aged adults. An isocaloric substitution with 5% of energy intake
from MUFA for 5% of energy intake from SFA (HR: 0.57, 95% CI: 0.34  0.95), PUFA
(HR: 0.56, 95% CI: 0.34  0.94), protein (HR: 0.57, 95% CI: 0.34  0.95) or carbohydrates
(excluding sugar) (HR: 0.50, 95% CI: 0.31  0.79) was associated with a lower CHD risk in
the middle-aged population. No signiﬁcant results were found among senior adults.
Conclusions  In this Norwegian population we observed that a higher intake of MUFA was
associated with a decreased risk of CHD in the middle-aged population. Based on our mod-
eled substitution analysis, it seems that substitution of different macronutrients with MUFA
may be associated with a lower CHD risk in the middle-aged population.
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Epicardial adiposity, regardless of visceral adiposity, is associated with significant
cardiovascular abnormalities in untreated and asymptomatic subjects, as measured
by the calcium score
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Topic: Obesity
Background: It has been postulated that excess epicardial fat (ECF) is associated with cardi-
ovascular disease (CVD) risk, yet a detailed association with calcium deposits has not been
reported.
Methods: We screened 2490 asymptomatic subjects for CVD risk using ECVDRS, which
consists of 10 tests: large (C1) and small (C2) artery stiffness, BP at rest and post mild exercise
(PME), CIMT, abdominal aorta and left ventricle ultrasound, retinal photography, micro-
albuminuria, ECG, and pro-BNP. 94 subjects underwent additional screening using CT scan
to assess ECF in millimeters as well as calcium deposits.
Results: The mean calcium score (CS) was higher for subjects with epicardial fat, irrespective
of their level of visceral adiposity. Non-obese subjects with excess ECF had an average CS of
265, whereas the non-obese with normal ECF had a mean CS of only 107. Similarly, the obese
with excess ECF had a signiﬁcantly higher mean CS than the obese without excess ECF. See
Figure 1 for detailed results.
Conclusions: 1) Abnormal levels of both micro and macrovascular stiffness were signiﬁcantly
higher in subjects with excess ECF than in those with normal ECF, irrespective of visceral
obesity, indicating that excess ECF is linked with vascular dysfunction. 2) The mean CS for
non-obese subjects with excess ECF was more than two and a half times higher than that of
the non-obese with normal ECF. This strongly suggests that excess ECF is associated with an
elevated CS. 3) Notably, the CS was higher in the non-obese with excess ECF than in the
obese with excess ECF, indicating that epicardial adiposity—and not visceral obesity—may
play a larger role in CV structural and functional abnormalities than previously thought.
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Attainment of blood pressure, lipids and diabetes targets in people at high cardio-
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Topic: Epidemiology
Purpose: The EUROASPIRE IV (EA IV) survey in primary care was carried out by the
European Society of Cardiology, EURObservational Research Programme in 2014-2015
and investigated risk factor management in patients at high cardiovascular (CVD) risk in14
European regions. The aim was to provide an audit of the Joint European Societies’ guidelines
on CVD prevention in people at high CVD risk in general practice and to see whether the
practice of preventive cardiology had improved by comparison with the previous
EUROASPIRE III (EA III) survey in 2006-2007.
Methods: All patients were free of coronary or other atherosclerotic disease but considered at
high CVD risk since they had been started on blood pressure (BP) and/or lipid and/or glucose
lowering treatments. They were interviewed and examined by means of standardized methods
6 months after the start of therapy.
Results: 4579 high CVD risk individuals (58% females), mean age 59 (SD 11) years, were
interviewed and examined (participation rate 68%). The risk factor control was very poor,
with less than half (43%) of the patients on BP lowering medication reaching the target of
<140/90 mmHg (< 140/80 mmHg in people with self-reported diabetes). Among treated
dyslipidaemic patients only 33% attained LDL-cholesterol (LDL-C) target of <2,5 mmol/
L. Among treated type 2 diabetic patients, 59% achieved the HbA1c target of < 7.0mmol/L.
However, many patients on no antihypertensive or lipid-lowering medications had elevated
blood pressure (46%) and elevated LDL-cholesterol (89%). The use of BP lowering medica-
tion in people with hypertension was ACE inhibitors/ARBs 80%, calcium channel blockers
29%, diuretics 38%, beta-blockers 37%. Among people on lipid-lowering medication, statins
were prescribed in 96% and ﬁbrates in 6%. The comparison with EUROASPIRE III in the
same centres participating in both surveys showed that the risk factor management remained
poor. BP was below guideline recommended targets in 28% in EA III and 35% in EA IV; the
LDL-C was < 2.5 mmol/L in 29% in EA III and 37% in EA IV and HbA1c was < 7% and
62% in EA III and 60% in EA IV.
Conclusions: The EA IV survey showed that large proportions of patients at high CVD risk
have uncontrolled blood pressure, lipids and diabetes with most patients not achieving the
targets deﬁned in the prevention guidelines. There is still further potential to improve the
management of patients at high CVD risk in Europe.
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Central vs. Cardiac Obesity
Non-obese subjectsBMI < 3047 subjects Obese subjectsBMI >/= 3047 subjects
Epicardial Fat (ECF) Normal ECFECF < 110 mm24 subjects Excess ECFECF >/= 11023 subjects Normal ECFECF < 110 mm6 subjects Excess ECFECF >/= 11041 subjects
Mean Age 58 60 57 58
Mean BMI 26.1 25.8 31.5 34.9
Mean Rasmussen Risk Score
(RRS)
4 7 6 7
Macro-arterial Stiffness
(C1)
83% normal20 out of 24
17% abnormal4 out of 24
70% normal16 out of 23
30% abnormal7 out of 23
100% normal6 out of 6
0% abnormal0 out of 6
85% normal35 out of 41
15% abnormal6 out of 41
Micro-arterial Stiffness
(C2)
88% normal21 out of 24
12% abnormal3 out of 24
65% normal15 out of 23
35% abnormal8 out of 23
83% normal5 out of 6
17% abnormal1 out of 6
63% normal26 out of 41
37% abnormal15 out of 41
Carotid Intima-Media
Thickness (CIMT)
67% normal16 out of 24
33% abnormal8 out of 24
57% normal13 out of 23
43% abnormal10 out of 23
50% normal3 out of 6
50% abnormal3 out of 6
46% normal19 out of 41
54% abnormal22 out of 41
Mean Calcium Score (CS) 107 265 20 202
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Translation of evidence from 11 randomized clinical trials on statin use in primary
prevention of cardiovascular disease into ESC 2016 and ACC/AHA 2013 guidelines:
results from the Rotterdam Study
J Jelena Pavlovic1, J W Deckers2, M Kavousi1, M A Ikram1, O H Franco1, M J
G Leening1
1Erasmus Medical Center, Epidemiology, Rotterdam, Netherlands, 2Erasmus Medical Center,
Cardiology, Rotterdam, Netherlands
Topic: Epidemiology
Background: Evidence from randomized clinical trials (RCTs) constitutes the base of the
European Society of Cardiology (ESC) 2016 and American College of Cardiology/
American Heart Association (ACC/AHA) 2013 guidelines for lipid-lowering treatment in
primary prevention of atherosclerotic cardiovascular disease (ASCVD).
Purpose: To quantify the contribution of 11 primary prevention RCTs to the practical appli-
cation of prevailing ESC and ACC/AHA guidelines.
Methods: From 1997-2008, 7279 participants aged 45-75 y, free of ASCVD, from the pro-
spective population-based Rotterdam Study cohorts were included (mean age 61.1 y; 58.2%
women). Eligibility of each participant was veriﬁed for every 1 of 11 double-blind placebo-
controlled RCTs on statin use in primary prevention of ASCVD, as well as for positive
recommendations on initiation of lipid-lowering therapy based on ESC 2016 and ACC/
AHA 2013 guidelines. Based on a mean 7.1 y follow-up, we calculated incidence rates (IRs)
per 1000 person-years (pys) for fatal and non-fatal ASCVD combined.
Results: The proportion of participants eligible for each of the 11 RCTs ranged from 0.4% for
ALLHAT-LLT to 30.8% for MEGA. A clear relationship was observed between the like-
lihood of ESC and ACC/AHA guideline recommendations for lipid-lowering treatment and
the observed ASCVD IR (Figure). Among trial eligible individuals, the proportion of indivi-
duals meeting positive guideline recommendations was lowest for low-to-intermediate risk
trials, including HOPE-3 (IR 7.8 per 1000 pys; ESC 12.1%; ACC/AHA 66.0%), MEGA
(IR 10.3 per 1000 pys; ESC 26.4%; ACC/AHA 55.5%), and JUPITER (10.6 per 1000 pys;
ESC 27.1%; ACC/AHA 68.1%), whilst RCTs done in diabetics (MRC/BHF HPS, CARDS,
and ASPEN; IRs >15.1 per 1000 pys; ESC >93.4%; ACC/AHA >92.4%), or older indivi-
duals (PROSPER; IR 23.6 per 1000 pys; ESC 90.0%; ACC/AHA 99.6%) had virtually com-
plete alignment with recommendations from both guidelines. Eligibility for an increasing
number of RCTs correlated with a greater likelihood of being recommended lipid-lowering
treatment by either guideline (ESC P=0.031; ACC/AHA p<0.001). Nearly half (48.1%) of
the individuals younger than 65 years who died from ASCVD during follow-up would not
qualify for lipid-lowering treatment based on the 2016 ESC prevention guidelines.
Conclusions: Compared to RCTs done in high risk populations, RCTs targeting low-to-inter-
mediate risk populations are less well-reﬂected in the ACC/AHA, and even less so in the ESC
guideline recommendations for primary prevention of ASCVD. Importantly, the low-to-inter-
mediate risk population targeted by HOPE-3, the most recent RCT in this ﬁeld, is not well-
captured by the current European prevention guidelines and should be speciﬁcally considered
in future iterations of the guidelines.
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The association between education level and cardiovascular disease incidence is
partially mediated by uncontrolled diabetes and hypertension and by smoking
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Topic: Social inequalities in cardiovascular health
Background: An inverse association between education and cardiovascular (CV) disease inci-
dence has been consistently observed. However, which are the mediating factors is not entirely
clear.
Purpose: To determine the mediating role of classical CV risk factors, lifestyles and treatments
in the association between education level and CV disease (CVD) incidence in a population-
based cohort.
Methods: We used the REGICOR population cohorts recruited in 1995, 2000 and 2005 in
north-eastern Spain. Participants underwent a physical examination and completed interview-
administered questionnaires at baseline and follow-up. Participants were followed for CV
events by interviews and data linkage. We included participants without previous CVD or
missing data (n=9233). We ﬁrst analysed the causal association between education and CVD
incidence at 6 years of follow-up using marginal structural models with education-and-cen-
soring inverse probability weights. Mediation of this association was assessed with structural
equation modelling based on logistic regression and diagonally weighted least-squares estima-
tion.
Results: Participants with a university degree had a CVD incidence hazard ratio of 0.51 (95%
conﬁdence interval (CI): 0.30-0.85) compared to those with primary or lower education. There
was no effect modiﬁcation be age or sex. Diabetes, hypertension and smoking were mediators
of this association while body mass index, physical activity and dyslipidemia were not.
Diabetes, hypertension, and smoking mediated 38% of the association between education
and CVD incidence. The effect of diabetes and hypertension was due to uncontrolled glucose
and blood pressure levels [indirect effect (95% CI)= a1*b1= -0.044 (-0.071, -0.017) and
a3*b3= -0.018 (-0.030, -0.006), respectively]. The effect of smoking was a4*b4= 0.007
(0.001, 0.013). The signiﬁcant pathways from education to mediators and from mediators
to CVD incidence, with all the individual effects (a1-a4 and b1-b4), are depicted in
the mediation ﬁgure.
Conclusions: The association between education level and CVD incidence at 6 years in the
REGICOR cohorts was partly mediated by smoking and by uncontrolled diabetes and hyper-
tension. These results suggest that improving smoking cessation rates and glucose and blood
pressure control could diminish part of the education inequalities associated to a higher CVD
risk.
Mediation ﬁgure
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